Paris, France – December 6, 2024. Following the press release on October 21, 2024 and the plan to transfer a 50% controlling stake in Opella (consumer healthcare division) to CD&R, the revised ...
Under the proposed deal, CD&R would acquire a 50% controlling interest in Opella, while Sanofi would retain a substantial ...
GlobalData on MSN1mon
Sanofi’s $17bn sale of Opella to US investors advances following government dealSanofi has entered exclusive talks with US private equity company Clayton Dubilier & Rice (CD&R) over the sale of the ...
(RTTNews) - Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare business, Opella, to private equity firm CD&R.
Sanofi is now in exclusive talks with private equity company Clayton Dubilier & Rice over the sale of a controlling stake in its consumer health business Opella, as the French government seeks to ...
Availability of the revised financial statements for Sanofi excluding Opella Paris, France – 6, 2024. Following the press release on October 21, 2024 and the plan to transfer a 50% controlling stake ...
Following the press release on October 21, 2024 and the plan to transfer a 50% controlling stake in Opella (consumer healthcare division) to CD&R, the revised financial statements for Sanofi ...
Availability of the revised financial statements for Sanofi excluding Opella Paris, France – December 6, 2024. Following the press release on October 21, 2024 and the plan to transfer a 50% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback